Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company’s Novel Business Model as Key to Sustainable Success through Patient Affordability Tevogen Bio is a fully functional biotech, with investor-valued assets over $10 billion achieved with under $40 million in spending.Approximately 78% of Tevogen Bio's common stock is held by company...

CRE Loan Stress Testing: Why Community Banks Aren't Off the Hook AUSTIN, Texas, Aug. 20, 2012 (GLOBE NEWSWIRE) -- In light of the combined FDIC, Federal Reserve, and OCC final guidance on Stress Testing for Banking Organizations Over $10 Billion in Assets released...